Glaucoma Is Associated with Peripheral Vascular Endothelial Dysfunction

Ophthalmology

Volumn 115, Issue 7, 2008, Pages

  Su, Wei Wen ^a   Cheng, Shih Tsung ^b   Ho, Wan Jing ^a   Tsay, Pei Kwei ^c   Wu, Shiu Chen ^a   Chang, Shirley H L ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETAXOLOL; BRIMONIDINE; BRINZOLAMIDE; C REACTIVE PROTEIN; CARTEOLOL; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; LATANOPROST PLUS TIMOLOL; TIMOLOL; TRAVOPROST;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VASCULAR ENDOTHELIUM; VISUAL FIELD;

EID: 45849087689     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.10.026     Document Type: Article

References (36)

1. Fechtner R.D., and Weinreb R.N. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol 39 (1994) 23-42
2. Flammer J., Orgul S., Costa V.P., et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21 (2002) 359-393
3. Tielsch J.M., Sommer A., Katz J., et al. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA 266 (1991) 369-374
4. Hitchings R.A. Low tension glaucoma-its place in modern glaucoma practice. Br J Ophthalmol 76 (1992) 494-496
5. Grosskreutz C., and Netland P.A. Low-tension glaucoma. Int Ophthalmol Clin 34 3 (1994) 173-185
6. Werner E.B. Normal-tension glaucoma. In: Ritch R., Shields M.B., and Krupin T. (Eds). The Glaucomas. 2nd ed. Vol. 2 (1996), Mosby, St. Louis 768-797
7. Parc C.E., Johnson D.H., Oliver J.E., et al. The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol 132 (2001) 27-35
8. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol 38 suppl (1994) S3-S6
9. Nakamura M., Yoshida H., Arakawa N., and Hiramori K. Endothelium-dependent vasodilator response is augmented in peripheral resistance vessels of patients with vasospastic angina. Cardiology 92 (1999) 85-92
10. Flammer J., Haefliger I.O., Orgul S., et al. Vascular dysregulation: a principal risk factor for glaucomatous damage?. J Glaucoma 8 (1999) 212-219
11. Anderson D.R. Glaucoma, capillaries and pericytes. 1. Blood flow regulation. Ophthalmologica 210 (1996) 257-262
12. Henry E., Newby D.E., Webb D.J., and O'Brien C. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci 40 (1999) 1710-1714
13. Buckley C., Hadoke P.W., Henry E., and O'Brien C. Systemic vascular endothelial cell dysfunction in normal pressure glaucoma. Br J Ophthalmol 86 (2002) 227-232
14. Su W.W., Cheng S.T., Hsu T.S., and Ho W.J. Abnormal flow-mediated vasodilation in normal-tension glaucoma using a noninvasive determination for peripheral endothelial dysfunction. Invest Ophthalmol Vis Sci 47 (2006) 3390-3394
15. Springer T.A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57 (1995) 827-872
16. Anderson T.J., Elstein E., Haber H., and Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol 35 (2000) 60-66
17. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
18. Verma S., Buchanan M.R., and Anderson T.J. Endothelial function testing as a biomarker of vascular disease. Circulation 108 (2003) 2054-2059
19. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713
20. Deanfield J.E., Halcox J.P., and Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 115 (2007) 1285-1295
21. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26 (1995) 1235-1241
22. Davignon J., and Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 109 (2004) III27-III32
23. Verhaar M.C., Honing M.L., van Dam T., et al. Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids. Cardiovasc Res 42 (1999) 752-760
24. ENCORE Investigators. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function). Circulation 107 (2003) 422-428
25. Kitazawa Y., Shirai H., and Go F.J. The effect of Ca2(+)-antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 227 (1989) 408-412
26. Netland P.A., Chaturvedi N., and Dreyer E.B. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol 115 (1993) 608-613
27. Ishida K., Yamamoto T., and Kitazawa Y. Clinical factors associated with progression of normal-tension glaucoma. J Glaucoma 7 (1998) 372-377
28. Koseki N., Araie M., Yamagami J., et al. Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure. J Glaucoma 8 (1999) 117-123
29. Nagaoka T., Takahashi A., Sato E., et al. Effect of systemic administration of simvastatin on retinal circulation. Arch Ophthalmol 124 (2006) 665-670
30. Webb D.J., and Haynes W.G. Endothelins come of age. Lancet 342 (1993) 1439-1440
31. Palmer R.M., Ashton D.S., and Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333 (1988) 664-666
32. Moncada S., and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
33. Sugiyama T., Moriya S., Oku H., and Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol 39 suppl (1995) S49-S56
34. Noske W., Hensen J., and Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract. Graefes Arch Clin Exp Ophthalmol 235 (1997) 551-552
35. Oku H., Sugiyama T., Kojima S., et al. Experimental optic cup enlargement caused by endothelin-1-induced chronic optic nerve head ischemia. Surv Ophthalmol 44 suppl (1999) S74-S84
36. Schmetterer L., and Polak K. Role of nitric oxide in the control of ocular blood flow. Prog Retin Eye Res 20 (2001) 823-847